Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program
- Author(s)
- Collis, B; Urbancic, K; Whitelaw, J; Reynolds, G; Vogrin, S; Jahanabadi, H; Pandey, D; Sinclair, M; Majumdar, A; Testro, A; Trubiano, JA; Smibert, OC;
- Journal Title
- Transplant Infectious Disease
- Publication Type
- Online publication before print
- Abstract
- BACKGROUND: Recent evidence suggests liver transplant recipients (LiTRs) with invasive aspergillosis (IA) have lower rates of dissemination and mortality compared to historical data. However, contemporary data from other centers remain scarce. We aimed to evaluate modern IA outcomes at our institution, where targeted perioperative echinocandin prophylaxis and an active antifungal stewardship program (AFSP) have been implemented. METHODS: This is a single-center retrospective analysis of patients who underwent liver transplantation between January 1, 2017 and June 30, 2022. During the study period, targeted anidulafungin perioperative prophylaxis was administered to patients considered high-risk for invasive fungal infection (IFI), and a multidisciplinary AFSP assisted with IFI diagnosis and management. Patients with proven and probable IA diagnosed post-operatively were identified using internationally accepted definitions. The primary outcomes were IA dissemination and 1-year all-cause mortality rates. Data were extracted from the electronic medical record and descriptive summary statistics were performed. RESULTS: Six patients (6/377, 1.6%) met the inclusion criteria. Patients with IA were significantly more likely to be colonized with multidrug-resistant Gram-negative organisms compared to those without IA (50.0% vs. 12.1%, p = 0.006). The median time to IA diagnosis was 22 days post-transplant (IQR 5-109). No cases of dissemination were observed. One-year all-cause mortality was 16.7%. CONCLUSION: Consistent with contemporary data, LiTRs had lower IA dissemination and mortality rates compared to earlier studies. These improved outcomes likely reflect a combination of modern advancements in liver transplantation, and we highlight two potentially modifiable interventions; targeted echinocandin prophylaxis and an AFSP. Further studies are needed to support their broader implementation.
- Keywords
- antifungal prophylaxis; antimicrobial stewardship; invasive aspergillosis; liver transplantation
- Department(s)
- Infectious Diseases
- Publisher's Version
- https://doi.org/10.1111/tid.70046
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-05-27 04:30:48
Last Modified: 2025-05-27 04:31:03